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INTRODUCTION 
 
 
Epilepsy is a neurological disorder affecting 
approximately 1% of the world's population.1 Epileptic 
seizures result in a set of brutal, unpredictable, and 
transient clinical manifestations resulting from the 
paroxysmal hyperactivity of a hyperexcitable neural 
network and its possible spread. Epilepsy treatment is 
based primarily on pharmacological treatment to 
reduce or even suppress the frequency of seizures and 
the pharmacodynamics of antiepileptic drugs vary 
according to the molecules, inducing one or more of 
these mechanisms: a strengthening of synaptic 
inhibition, a decrease in synaptic arousal, or even 
stabilization of cell membranes. 
 
Because of their specific mechanism of action, 
antiepileptic drugs have indications in the treatment of 
one or more forms of epilepsy.  Carbamazepine, sodium 
valproate, lamotrigine, levetiracetam can be used in 
several indications, such as generalized seizures tonic 
clonic seizures, absence seizures, myoclonia or partial 
seizures. Apart from epilepsy, certain molecules are also 
indicated in the treatment of bipolar syndromes, 
neuropathic pain, or certain facial neuralgia. 
 
From a safety perspective, antiepileptics have a pattern 
of adverse events that vary from molecule to molecule, 
which may lead the clinician to reassess the patient's 
individual benefit/risk ratio. Among the most well-
known examples, particularly due to their severity, are 
Stevens-Johnson syndromes due to lamotrigine2, 
hyponatremias with carbamazepine and 
oxcarbazepine3,      gingival        hypertrophies      under  
   
phenytoin4 or fetal malformations following sodium 
valproate.5 In addition, pharmacological therapeutic 
follow-up may be performed at the individual level due 
to a narrow therapeutic margin and/or the risk of drug 
interactions for certain molecules.6-8 
 
Because of their diffusion to the central nervous system, 
antiepileptic drugs expose patients to neurological 
adverse effects. Cognitive disorders under 
phenobarbital and aggressive states under lacosamide, 
felbamate, lamotrigine or levetiracetam are fairly well 
described examples, especially in the paediatric 
population.9 Hamed SA in a review reported that long-
term use of certain antiepileptic drugs was associated 
with the rare occurrence of tinnitus, hearing loss, or 
dizziness, including therapeutic doses. Although 
mostly reversible, these audio-vestibular abnormalities 
may persist despite discontinuation of treatment.10 
These hearing disorders appear to be less present in the 
collective consciousness of health professionals, 
potentially explained by the rarity of these adverse 
effects and non-serious symptomatology.  
 
In the literature, the majority of hearing disorders in the 
perception of antiepileptic sounds concern 
carbamazepine. Tateno et al. published a case series of 
six cases of change in tone perception under 
carbamazepine and identified a few previously published 
cases.13 The time frames for appearance, when specified, 
ranged from a few hours to two weeks after the 
introduction of CBZ. For all reported cases, the patients 
were  all  musicians,  often  possessing  the  absolute  ear,  
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and probably more likely to notice moderate variations 
in tone perception than other patients treated with CBZ. 
The dosages used ranged from 100 to 600mg/day. Three-
quarters were treated for epilepsy (with no particular 
profile reported), the rest for psychiatric disorders or 
neuropathic pain.11 In the majority of patients, the 
adverse reaction rapidly regressed to the discontinuation 
of the offending drug or the decrease in dosage. Some 
patients, however, appeared to see a spontaneous 
improvement in symptoms despite continued treatment 
at the same dose.  
 
Another case of hearing impairment in an epileptic 
subject has been reported with anti-epileptic drugs as 
causative agents.12 whose symptoms disappeared despite 
the continuation of treatment at the same dosage. A 
genetic predisposition can be evoked but so far none of 
the authors who reported the cases have discussed this 
point. 
 
Till date, carbamazepine, oxcarbazepine and lacosamide 
have been reported in the literature to be associated with 
the occurrence of sound perception disorders. Their 
mechanism of action could be the common feature of 
this pathophysiology, exceeding the hypothesis of a 
structural-toxicity relationship, since these are different. 
The mechanisms involved in the occurrence of these 
tonal perception anomalies are not elucidated for any of 
these molecules. However, several hypotheses have been 
raised, such as the possibility of a direct effect on the 
central nervous system. Indeed, interference with the 
sodium channels would alter the action potential of the 
auditory nerves and cochlear nuclei of the brainstem 
[10]. Furthermore, hypotheses of local action on the 
auditory system, with modification of the mechanical 
properties of the hair cells of Corti's organ, or an action 
on the sarcolemma of the ear muscle, affecting the 
tension of the tympanic membrane.11-14 
 
Changing the perception of sounds is a very rare adverse 
effect of carbamazepine, oxcarbazepine and lacosamide, 
identified in the literature. Rapid onset after the 
introduction of treatment, a complete resolution of 
symptoms, in most cases at the end of treatment, is 
observed, without any after-effects appear to be 
reported. Because of the impact on quality of life due to 
impairment of a basic sensory organ, knowledge of this 
adverse effect seems important to evoke this diagnosis. 
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